Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry.

Talanta · 2015 · PMC4196769 · PMID 25281165

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a strong trendp =0.06so close (0.05 < p ≤ 0.1)

Androstenedione, a further substrate also increased significantly following dutasteride treatment, with a strong trend evident with finasteride ( p =0.06).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.